Enliven Therapeutics (ELVN) Shares Outstanding (Entity) (2020 - 2026)

Enliven Therapeutics (ELVN) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 254.16 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 147.69 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 200.18 Mn
10 Enliven Therapeutics 3.22 Bn 3.22 Bn - 60.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 60.89 Mn
Dec 31, 2025 59.44 Mn
Sep 30, 2025 59.26 Mn
Jun 30, 2025 59.23 Mn
Mar 31, 2025 49.04 Mn
Dec 31, 2024 48.94 Mn
Sep 30, 2024 47.25 Mn
Jun 30, 2024 47.17 Mn
Mar 31, 2024 46.78 Mn
Dec 31, 2023 41.29 Mn
Sep 30, 2023 41.20 Mn
Jun 30, 2023 41.15 Mn
Mar 31, 2023 18.51 Mn
Dec 31, 2022 6.57 Mn
Sep 30, 2022 6.57 Mn
Jun 30, 2022 6.57 Mn
Mar 31, 2022 6.57 Mn
Dec 31, 2021 5.42 Mn
Sep 30, 2021 6.57 Mn
Jun 30, 2021 4.48 Mn